EQS-News

Brazil's Tobacco Health Cost Recovery Lawsuit Reaches Critical Milestone as Court Prepares to Rule 30.07.2026, 16:15 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: Campaign for Tobacco-Free Kids / Key word(s): Miscellaneous/Miscellaneous
Brazil's Tobacco Health Cost Recovery Lawsuit Reaches Critical Milestone as Court Prepares to Rule

30.07.2026 / 16:15 CET/CEST
The issuer is solely responsible for the content of this announcement.


Statement of Yolonda C. Richardson, President and CEO of Campaign for Tobacco-Free Kids

WASHINGTON, July 30, 2026 /PRNewswire/ -- A landmark lawsuit filed in 2019 by Brazil's Office of the Attorney General (Advocacia-Geral da União, or AGU) seeking to hold the country's largest cigarette manufacturers financially accountable for the enormous public health costs caused by smoking has reached a critical milestone. All legal submissions are now complete, including an opinion from the Federal Public Prosecutor's Office supporting the AGU's claims. The case is now awaiting a decision before the Federal Court in Porto Alegre on whether the tobacco companies are liable for the harms caused by the marketing and sale of their cigarettes in Brazil.

Campaign for Tobacco-Free Kids logo. (PRNewsFoto/Campaign for Tobacco-Free Kids)

The lawsuit seeks to require the country's largest cigarette manufacturers to compensate Brazil's public health system for healthcare expenditures related to diseases scientifically linked to tobacco use. The defendants include BAT Brasil (formerly Souza Cruz) and Philip Morris Brasil, and their parent companies, British American Tobacco and Philip Morris International.

The case is one of the world's most significant tobacco health cost recovery lawsuits and could have implications far beyond Brazil. If successful, the case would reinforce the principle that tobacco companies should be held accountable for the enormous health and economic costs caused by their products.

Tobacco use imposes an enormous burden on Brazil's public health system. Each year, smoking causes approximately 177,000 deaths and costs an estimated R$75 billion (almost US$15 billion) in healthcare expenditures to treat tobacco-related diseases. The lawsuit argues that although the manufacture and sale of cigarettes are lawful activities, companies remain legally responsible for compensating society for the damages caused by their products.

Brazil's lawsuit is the first of its kind in a low- or middle-income country to reach a liability ruling. Similar health cost recovery actions have been pursued in other countries, including Canada and the United States, where governments have successfully sought compensation for healthcare expenditures attributable to tobacco use.

The tobacco industry has caused enormous and well-documented public health harm in Brazil. A favorable ruling would not only represent a major milestone for Brazil but will also establish an important precedent for governments seeking to hold the tobacco industry accountable.

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/brazils-tobacco-health-cost-recovery-lawsuit-reaches-critical-milestone-as-court-prepares-to-rule-302839145.html

rt.gif?NewsItemId=EN15717&Transmission_Id=202607301000PR_NEWS_EURO_ND__EN15717&DateId=20260730


30.07.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2374818  30.07.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Weitere News

Gestern 20:36 Uhr • Artikel • dpa

Gestern 15:37 Uhr • Artikel • BörsenNEWS.de

Gestern 15:05 Uhr • Artikel • BörsenNEWS.de

Gestern 13:23 Uhr • Artikel • dpa

Gestern 12:13 Uhr • Artikel • dpa

Gestern 9:51 Uhr • Artikel • BörsenNEWS.de

Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer